Phase 2 Study of Dacomitinib in NSCLC
Phase 2 Study of Dacomitinib in NSCLC
Active, not recruiting · NCT04027647 · Registry updated 2025-06-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 2 Study of Dacomitinib in NSCLC | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 2 | 2025-06-12 | NCT04027647 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Centre, Singapore | 44 |
| Pfizer | 431 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beacon Hospital | Petaling Jaya | Malaysia | 1 |
| Dong-A University Hospital | Busan | South Korea | 20 |
| National Cancer Centre Singapore | Singapore | Singapore | 8 |
| Phramongkutklao Hospital | Bangkok | Thailand | 9 |
| Prince of Wales Hospital | Hong Kong | Hong Kong | 81 |
| Ramathibodi Hospital | Bangkok | Thailand | 7 |
| Sarawak General Hospital | Kuching | Malaysia | 3 |
| Seoul National University Hospital | Seoul | South Korea | 183 |
| University Malaya Medical Centre | Kuala Lumpur | Malaysia | 8 |